Clinical research networks and assessing pandemic severity.
作者信息
Murthy Srinivas, Carson Gail, Horby Peter, Merson Laura, Webb Steve
机构信息
University of British Columbia, Vancouver, BC V6H 3V4, Canada; International Severe and Acute Respiratory and Emerging Infections Consortium, Oxford, UK.
Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK; International Severe and Acute Respiratory and Emerging Infections Consortium, Oxford, UK.
出版信息
Lancet Glob Health. 2019 Jan;7(1):e33. doi: 10.1016/S2214-109X(18)30413-3.
Abstract
摘要
相似文献
1
Clinical research networks and assessing pandemic severity.
Lancet Glob Health. 2019 Jan;7(1):e33. doi: 10.1016/S2214-109X(18)30413-3.
2
Degree of adherence to recommended antiviral treatment during the pandemic and post-pandemic periods of influenza A(H1N1)pdm09 in 148 intensive care units in Spain.
Med Intensiva. 2015 May;39(4):222-33. doi: 10.1016/j.medin.2014.06.001. Epub 2014 Aug 5.
3
Antiviral treatment for pandemic influenza: assessing potential repercussions using a seasonally forced SIR model.
J Theor Biol. 2011 Nov 21;289:259-68. doi: 10.1016/j.jtbi.2011.08.011. Epub 2011 Aug 18.
4
Pre-and post-pandemic trends in antiviral use in hospitalized patients with laboratory-confirmed influenza: 2004/05-2013/14, Toronto, Canada.
Antiviral Res. 2017 Apr;140:158-163. doi: 10.1016/j.antiviral.2017.01.025. Epub 2017 Feb 6.
5
Pandemic influenza H1N1 2009--the Canadian experience.
J Popul Ther Clin Pharmacol. 2010 Fall;17(3):e358-62. Epub 2010 Oct 26.
6
Antiviral agents: to treat or not to treat? An old dilemma revisited in light of new data from the 2009 influenza A(H1N1) pandemic.
J Clin Virol. 2010 Oct;49(2):145-6. doi: 10.1016/j.jcv.2010.07.001. Epub 2010 Aug 2.
7
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.
J Infect Dis. 2011 Dec 15;204(12):1848-56. doi: 10.1093/infdis/jir648. Epub 2011 Oct 19.
8
Value for Money in H1N1 Influenza: A Systematic Review of the Cost-Effectiveness of Pandemic Interventions.
Value Health. 2017 Jun;20(6):819-827. doi: 10.1016/j.jval.2016.05.005. Epub 2016 Jun 29.
9
Overview/reflections on the 2009 H1N1 pandemic.
Microbes Infect. 2011 May;13(5):470-8. doi: 10.1016/j.micinf.2011.01.009. Epub 2011 Jan 27.
10
Influenza A(H1N1)pdm09 in England, 2009 to 2011: a greater burden of severe illness in the year after the pandemic than in the pandemic year.
Euro Surveill. 2012 Apr 5;17(14):20139.
引用本文的文献
1
Characteristics and outcomes of patients with COVID-19 admitted to hospital and intensive care in the first phase of the pandemic in Canada: a national cohort study.
CMAJ Open. 2021 Mar 8;9(1):E181-E188. doi: 10.9778/cmajo.20200250. Print 2021 Jan-Mar.
本文引用的文献
1
Clinical research networks are key to accurate and timely assessment of pandemic clinical severity.
Lancet Glob Health. 2018 Sep;6(9):e956-e957. doi: 10.1016/S2214-109X(18)30304-8.
2
Global Variability in Reported Mortality for Critical Illness during the 2009-10 Influenza A(H1N1) Pandemic: A Systematic Review and Meta-Regression to Guide Reporting of Outcomes during Disease Outbreaks.
PLoS One. 2016 May 12;11(5):e0155044. doi: 10.1371/journal.pone.0155044. eCollection 2016.
3
Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1.
Biosecur Bioterror. 2011 Jun;9(2):89-115. doi: 10.1089/bsp.2011.0007.
4
InFACT: a global critical care research response to H1N1.
Lancet. 2010 Jan 2;375(9708):11-3. doi: 10.1016/S0140-6736(09)61792-X. Epub 2009 Nov 10.
Zotero 插件